These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31297950)

  • 41. Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
    Pascual-Pasto G; Olaciregui NG; Opezzo JAW; Castillo-Ecija H; Cuadrado-Vilanova M; Paco S; Rivero EM; Vila-Ubach M; Restrepo-Perdomo CA; Torrebadell M; Suñol M; Schaiquevich P; Mora J; Bramuglia GF; Chantada GL; Carcaboso AM
    J Control Release; 2017 Oct; 264():34-44. PubMed ID: 28830790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinoblastoma.
    Mehta M; Sethi S; Pushker N; Kashyap S; Sen S; Bajaj MS; Ghose S
    Singapore Med J; 2012 Feb; 53(2):128-35; quiz 136. PubMed ID: 22337189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombospondin-1 might be a therapeutic target to suppress RB cells by regulating the DNA double-strand breaks repair.
    Chen P; Yu N; Zhang Z; Zhang P; Yang Y; Wu N; Xu L; Zhang J; Ge J; Yu K; Zhuang J
    Oncotarget; 2016 Feb; 7(5):6105-20. PubMed ID: 26756218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
    Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma.
    Yarovoy AA; Ushakova TL; Gorshkov IM; Polyakov VG; Golubeva OV; Gorovtsova OV; Krivovyaz OS
    Eur J Ophthalmol; 2015 Dec; 26(1):e17-9. PubMed ID: 26428220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rhegmatogenous retinal detachment following treatment for retinoblastoma.
    Saumya Pal S; Gopal L; Khetan V; Nagpal A; Sharma T
    J Pediatr Ophthalmol Strabismus; 2010; 47(6):349-55. PubMed ID: 20055334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitreous humor rheology after Nd:YAG laser photo disruption.
    Abdelkawi SA; Abdel-Salam AM; Ghoniem DF; Ghaly SK
    Cell Biochem Biophys; 2014 Mar; 68(2):267-74. PubMed ID: 23797611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
    Abramson DH; Schefler AC
    Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The radioprotector ortho-phospho-L-tyrosine (pTyr) attenuates the side effects of fractionated irradiation in retinoblastoma mouse models but also decreases the local tumour control.
    Tschulakow AV; Dittmann K; Huber SM; Klumpp D; Stegen B; Schraermeyer U; Rodemann HP; Julien-Schraermeyer S
    Radiother Oncol; 2017 Sep; 124(3):462-467. PubMed ID: 28711224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoblastoma.
    Aerts I; Lumbroso-Le Rouic L; Gauthier-Villars M; Brisse H; Doz F; Desjardins L
    Orphanet J Rare Dis; 2006 Aug; 1():31. PubMed ID: 16934146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimally invasive method for repair of rhegmatogenous retinal detachment following treatment for retinoblastoma.
    Buerk BM; Lai WW; Sharma MC; Shapiro MJ
    Ophthalmic Surg Lasers Imaging; 2006; 37(1):82-5. PubMed ID: 16468560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Available approaches to retinoblastoma therapy--literature review].
    Morawski K; Kulig-Stochmal A; Drychowska-Jęmhorska JJ; Kuhicka-Trząska A; Romanowska-Dixon B
    Klin Oczna; 2015; 117(1):45-9. PubMed ID: 26349159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Retinoblatoma: a review].
    Doz F
    Arch Pediatr; 2006 Oct; 13(10):1329-37. PubMed ID: 16930963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thermochemotherapy in hereditary retinoblastoma.
    Murthy R; Honavar SG; Naik M; Reddy VA
    Br J Ophthalmol; 2003 Nov; 87(11):1432. PubMed ID: 14609861
    [No Abstract]   [Full Text] [Related]  

  • 57. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.
    Sreenivasan S; Thirumalai K; Danda R; Krishnakumar S
    Curr Eye Res; 2012 May; 37(5):421-8. PubMed ID: 22510010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Eyeball salvage treatment or enucleation for advanced retinoblastoma].
    Qian J; Xue K
    Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):728-732. PubMed ID: 27760644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.